About TETRATHERIX LIMITED
Sector
Website
Headquarters
Sydney
Founded
2015
ISIN
AU0000400574
FIGI
BBG01VGZ4VL9
Tetratherix Ltd. engages in the development of a biostealth fluid matrix for regenerative medicine. The firm offers Tetramatrix as its primary product. It develops a biostealth fluid matrix that evolves regenerative medicine through the use of the firm's Tetramatrix platform technology. The company was founded by Terence Abrams and Ali Fathi and is headquartered in Sydney, Australia.
Related stocks
Frequently Asked Questions
The current price of TTX is 4.49 AUD — it has increased by 4.19% in the past 24 hours. Watch TETRATHERIX LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange TETRATHERIX LIMITED stocks are traded under the ticker TTX.
TTX stock has risen by 34.94% compared to the previous week, the month change is a 34.94% rise, over the last year TETRATHERIX LIMITED has showed a 35.24% increase.
No, TTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TETRATHERIX LIMITED stock right from TradingView charts — choose your broker and connect to your account.